Diseases, Conditions, Syndromes

HIV sufferers need hepatitis safeguards

Stronger protections are needed to prevent people with HIV from also becoming infected with hepatitis, researchers argue in a new study led by Michigan State University.

Cardiology

Metal stents are effective treatment for blocked bile ducts

A multi-center analysis, led by Weill Cornell Medical College and published in the Journal of Clinical Gastroenterology, shows the use of temporary "fully covered self-expanding metal stents" (FCSEMS) can effectively fix ...

Medical research

Anti-ageing drug breakthrough

Drugs that combat ageing may be available within five years, following landmark work led by an Australian researcher. The work, published in the March 8 issue of Science, finally proves that a single anti-ageing enzyme in ...

Medical research

NIH develops improved mouse model of alcoholic liver disease

(Medical Xpress)—Scientists may be better able to study how heavy drinking damages the liver using a new mouse model of alcohol drinking and disease developed by researchers from the National Institute on Alcohol Abuse ...

Genetics

EU releases 144 mn euro for new rare disease research

The European Union on Thursday pledged 144 million euros of fresh funding for research on rare diseases that currently affect some 30 million Europeans, the majority of them children.

Surgery

Risk factors ID'd for cervical spinal surgery complications

(HealthDay)—Risk factors have been identified for medical complications following cervical spine surgery, with cardiac and pulmonary complications correlating with death within two years, according to research published ...

Diseases, Conditions, Syndromes

In a fight to the finish, research aims knockout punch at hepatitis B

In research published in the Jan. 24 edition of PLOS Pathogens, Saint Louis University investigators together with collaborators from the University of Missouri and the University of Pittsburgh report a breakthrough in the ...

Diseases, Conditions, Syndromes

Chronic hepatitis C: Interferon may be harmful in re-treatment

People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying sooner, and are ...

Diseases, Conditions, Syndromes

Are some patients too heavy for a new kidney?

In a research review article published in the American Journal of Nephrology, Saint Louis University investigators examined data from multiple studies to better understand how obesity, an epidemic in the U.S., impacts kidney ...

page 29 from 40